FDA Approves Frontline Immunotherapy for Gastric Cancers
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
Home »
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
For patients with inoperable pancreatic cancer, higher dose ablative radiation after chemotherapy induction may extend life, say investigators from Memorial …
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive …
A novel radiopharmaceutical was more active than cabazitaxel against metastatic castration-resistant prostate cancer (mCRPC) and caused fewer grade 3/4 adverse …
The stem cells used in a transplant are collected from the blood or sometimes the bone marrow. The first step …
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TEVATREXED® VERSION 1.0 Pemetrexed disodium Consumer Medicine …
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KANJINTI® Intravenous infusion Contains the active ingredient …
Colorectal sarcoma is a very rare type of mesenchymal cancer that develops in the lower gastrointestinal (GI) tract. Image Credit: …
Giving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence …
R-CHOP consists of five separate drugs. These are: (R) rituximab (Rituxan) (C) cyclophosphamide (H) doxorubicin hydrochloride (O) vincristine (Oncovin, Vincasar …